PT Sunrise Health Initiative is a leading integrated diagnostic and treatment solution provider in Indonesia. Deeply rooted in the precision medicine sector, the company has built a full industrial chain ecosystem. Its business scope covers medical devices and consumables, in vitro diagnostic (IVD) products, comprehensive medical solutions, and pharmaceutical products.

We uphold our vision: Making life science technology accessible to all; and our mission: To deliver affordable, high-efficiency precision diagnostic technologies, products and services for the people of Indonesia. The company continuously introduces cutting-edge international precision medical technologies and products to facilitate the standardization of Indonesia’s precision medicine system, improve the hierarchical diagnosis and treatment network, and comprehensively enhance the accessibility and quality of local medical services.

Looking ahead, the company will keep focusing on innovations in gene technology and vigorously implement the "Five Modernizations" development strategy: High Precision, Simplicity, Systematization, Mobility, and Intelligence.

- High Precision consolidates the core value of diagnosis;

- Simplicity lowers the barriers for clinical application;

- Systematization establishes a full-process service system;

- Mobility expands the boundaries of medical services;

- Intelligence empowers efficient diagnosis and treatment decision-making.

PT Sunrise Health Initiative is committed to continuously injecting strong momentum into the global development of precision medicine.